Skip to main content

Highlights

  1. 1
    PEC innovation · 2023
    PMID: 37214514PMCID: PMC10194207DOISenior author37 citations
  2. 2
    American journal of obstetrics and gynecology · 2020
    PMID: 32598911PMCID: PMC7318934DOIFirst author106 citations
  3. 3
    American journal of obstetrics and gynecology · 2024
    PMID: 38621481DOISenior author13 citations

Publications

177 publications

Active

5 grants
  • MPI
    IGNITE-TX
    NCI · 2026–2031 · via NIH RePORTER
    R01CA308143-01A1
  • Co-I
    Bridging Gaps and Transforming CARE for Young Breast Cancer Survivors and those with Metastatic Disease
    Centers for Disease Control and Prevention · 2024–2029
    No publications yet
    NU58DP007916-01-00
  • PI
    Evaluating At-Risk Relative Experience with Chatbot-Facilitated Cascade Genetic Testing
    American Association of Obstetricians & Gynecologists Foundation · 2026–2027
    AAOG 261431-01
  • PI
    Randomized controlled trial of facilitated cascade testing for BRCA 1/2 mutations
    GOG Foundation, Inc. · 2023–2026
    GOG 215404-03
  • MPI
    Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling
    National Human Genome Research Institute · 2022–2026 · via Memorial Sloan Kettering Cancer Center
    R01HG011914-03
Completed grants (4)
  • PI
    Intercampus Academic Integration Research Symposium:Hereditary Cancer,
    Cornell University - Ithaca · 2023–2025
    CUI 235270-01
  • Co-I
    Disparities in COVID Disease Severity and Outcomes in New York City
    National Center for Advancing Translational Sciences · 2020–2022
    UL1TR002384-04S1
  • MPI
    Clinical and Translational Science Center - KL2
    National Center for Advancing Translational Sciences · 2017–2022Career
    KL2TR002385-01
  • PI
    'CascadeNet': Developing an online site with telephone-based, cascade genetic testing counseling scripts for health-care providers
    Foundation for Women's Cancer · 2021–2022
    FWC 213865-01

Clinical research

11 studies

Active

4 studies
  • PI
    Hereditary Breast Cancer Treatment Study: Retrospective Data Abstraction at Weill Cornell Medicine
    Women's College Hospital · OPEN TO ACCRUAL (as of 2026)
  • PI
    Feasibility of Obstetric and Cancer Universal Screening
    NA · Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
    Hereditary Cancer Syndromes
    NCT07052266
  • PI
    EPIC Registry for Patients with Hereditary Cancer Syndromes Receiving Care at The Genetics and Personalized Cancer Prevention Program
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2023)
  • PI
    Evaluation of a Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment in an Underserved Gynecology Population
    NA · Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2022)
    Gynecologic Cancer; Hereditary Cancer Syndrome
    NCT05562778
Completed & closed trials (7)
  • PI
    Expanding obstetric carrier screening: Patient understanding of and goals for obstetric carrier screening
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2026)
  • PI
    Randomized Controlled Trial of Accessible Online Genetic Services for Cascade Testing for BRCA Mutation Carriers Versus Usual Care in a Clinic Setting
    NA · Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)
    BRCA1 Mutation; BRCA2 Mutation
    NCT04613440
  • PI
    Incorporating sexual health into the care of patients with hereditary breast and ovarian cancer (BRCA1/BRCA2), Lynch, and other hereditary cancer syndromes: patient perspectives
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2025)
  • PI
    COVID-19 and Gynecologic Oncology Patients
    New York University Medical Center · IRB STUDY CLOSURE (as of 2025)
  • PI
    A Retrospective Review of Breast Cancer Risk Assessment in a Diverse, Publicly Insured Obstetrics/Gynecology Clinic Population
    Weill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2025)
  • PI
    Medical student experience in Washington and New York state during SARS-CoV-2/COVID-19 pandemic
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2023)
  • PI
    A Novel Strategy for Cascade Testing of At-Risk Relatives of Individuals with Hereditary Cancer Syndromes Using Targeted Genetic Counseling and Mailed Saliva Kits
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2023)

News mentions

Media highlights

1 clip

External relationships

Other

AMPA Biosciences INC · WndrHLTH